The Distribution and Biological Fuction of Pituitary Adenylate Cyclase Activating Polypeptide

Tang Sheng-Qiu,Dong Xiao-ying,Zou Xiao-ting

2004-01-01

Abstract:Pituitary adenylate cyclase activating polypeptide(PACAP) was a new discovered nerve peptide, which had manifold biological activities.Molecular structure, gene constitute, organizational apparatus distrib- uting and biological function of PACAP were summarized in this article.

What problem does this paper attempt to address?

Research advance of pituitary adenylate cyclase activating polypeptide

Yue Shuangming,Wang Zhisheng,Liu Huifang

DOI: https://doi.org/10.3969/j.issn.1001-991X.2007.11.004

2007-01-01

Abstract:Pituitary adenylate cyclase activating polypeptide belongs to the secretin/glucagons/VIP family, it can stimulate c AMP formation in pituitary cells, it acts many kinds of biological functions, This article is about PACAP affects the digestion of nutrition, animals production and maintains animals energy balance and animal immune system and soon.
Pituitary Adenylate Cyclase-Activating Polypeptide and Its Receptors: 20 Years after the Discovery

David Vaudry,Anthony Falluel-Morel,Steve Bourgault,Magali Basille,Delphine Burel,Olivier Wurtz,Alain Fournier,Billy K. C. Chow,Hitoshi Hashimoto,Ludovic Galas,Hubert Vaudry

DOI: https://doi.org/10.1124/pr.109.001370

2009-09-01

Pharmacological Reviews

Abstract:Pituitary adenylate cyclase-activating polypeptide (PACAP) is a 38-amino acid C-terminally alpha-amidated peptide that was first isolated 20 years ago from an ovine hypothalamic extract on the basis of its ability to stimulate cAMP formation in anterior pituitary cells (Miyata et al., 1989. PACAP belongs to the vasoactive intestinal polypeptide (VIP)-secretin-growth hormone-releasing hormone-glucagon superfamily. The sequence of PACAP has been remarkably well conserved during evolution from protochordates to mammals, suggesting that PACAP is involved in the regulation of important biological functions. PACAP is widely distributed in the brain and peripheral organs, notably in the endocrine pancreas, gonads, respiratory and urogenital tracts. Characterization of the PACAP precursor has revealed the existence of a PACAP-related peptide, the activity of which remains unknown. Two types of PACAP binding sites have been characterized: type I binding sites exhibit a high affinity for PACAP and a much lower affinity for VIP, whereas type II binding sites have similar affinity for PACAP and VIP. Molecular cloning of PACAP receptors has shown the existence of three distinct receptor subtypes: the PACAP-specific PAC1-R, which is coupled to several transduction systems, and the PACAP/VIP-indifferent VPAC1-R and VPAC2-R, which are primarily coupled to adenylyl cyclase. PAC1-Rs are particularly abundant in the brain, the pituitary and the adrenal gland, whereas VPAC receptors are expressed mainly in lung, liver, and testis. The development of transgenic animal models and specific PACAP receptor ligands has strongly contributed to deciphering the various actions of PACAP. Consistent with the wide distribution of PACAP and its receptors, the peptide has now been shown to exert a large array of pharmacological effects and biological functions. The present report reviews the current knowledge concerning the pleiotropic actions of PACAP and discusses its possible use for future therapeutic applications.

pharmacology & pharmacy
The Distrion of PACAP Receptor on the Cardiovascular Tissues and Cells

常青,李自成,邓漪平

DOI: https://doi.org/10.3969/j.issn.1001-1439.2002.07.017

2002-01-01

Journal of Clinical Cardiology

Abstract:Objective:To understand the distribution of pituitary adenylate cyclase activating polypeptide (PACAP) receptor on the cardiovascular tissues and cells. Method:Radioligand binding assay was used with 125 I PACAP as radioligand. Result:The content of PACAP receptor on the ventricle is (88.707±46.182) fmol/mg protein and ( 157.347 ± 84.440 ) fmol/mg protein on the aorte, but on the lung is ( 1 777.967 ± 88.712 ) fmol/mg protein. The density of PACAP receptor on the endothelial cell (EC) is (6 699± 853.132 ) bite/cell and (2 784± 792.430 ) bite/cell on the smath muscel cell (SMC). Conclusion:The number of PACAP receptor on the heart is scarce and the density of PACAP receptor on ECs is greater than that on SMCs significantly. PACAP effects on the cardiovascular system may have the aid of the activating of post receptor way except receptor activated.
Expression,Purification and Activity of Pituitary Adenylate Cyclase-activting Polypeptide 38 and Its Derivative

ZHANG Hong-dan,XIAO Lei,ZHAO Li-fen,Xiao X. Wang,HUANG Jing,WU Zi-rong

DOI: https://doi.org/10.13200/j.cjb.2011.05.35.zhanghd.017

2011-01-01

Abstract:Objective To improve the in vivo stability and prolong the half-life of bioactivity of pituitary adenylate cyclase-activting polypeptide 38(PACAP38).Methods The amino acid sequence of PACAP38 was modified to obtain a derivative named cPACAP38.The gene fragments encoding PACAP38 and cPACAP38 were designed and synthesized according to the codon bias of E.coil and cloned into vector pET-32a(+).The constructed recombinant plasmids were transformed to E.coli BL21(DE3) for expression under induction of IPTG.The expressed fusion proteins were purified by nickel ion affinity chromatography and digested with enterokinase,by which two target polypeptides were obtained and tested for anorexigenic activities in mice.Mice were treated with the polypeptides for 10 d,then determined for intraperitoneal glucose-resistance as well as serum triglyceride,HDL,LDL and cholesterol contents.Results Fusion proteins Trx-PACAP38 and Trx-cPACAP38 were expressed in soluble forms,which contained 22% and 25% of total somatic proteins and reached purities of 90% and 98% after purification respectively.Both PACAP38 and cPACAP38 showed anorexigenic activities in mice.However,the anorexigenic activity of cPACAP38 was higher than that of PACAP38.No significant changes were observed in intraperitoneal glucose-resistance as well as serum triglyceride,HDL,LDL and cholesterol contents of mice 10 d after treatment with the fusion proteins.Conclusion The derivative of PACAP38 with higher in vivo activity was successfully expressed,which laid a foundation of basic study and application of PACAP38.
Homology Modeling and Molecular Docking of Human Pituitary Adenylate Cyclase-Activating Polypeptide I Receptor

Lusheng Wu,Wenhua Guang,Xiaojia Chen,An Hong

DOI: https://doi.org/10.3892/mmr.2014.2419

IF: 3.423

2014-01-01

Molecular Medicine Reports

Abstract:Pituitary adenylate cyclase-activating peptide I receptor (PAC1R) is member of the B class of G protein-coupled seven-transmembrane receptors, with molecular functions associated with neural cell differentiation, regeneration and the inhibition of apoptosis. However, the integrity of the protein structure is difficult to be determined in vitro. In the present study, the physicochemical properties of PAC1R were analyzed, the extracellular, transmembrane and intracellular regions were constructed and a three-dimensional structure model of PAC1R was produced using extracellular loop region optimization and the energy minimization homology modeling method. Preliminary studies on the PAC1R protein and ligand interactions used a molecular docking method. The results indicated that the interaction sites of PAC1R were at Ile63, Ser100 and Gln105. These were the sites where the PAC1R combined with a hydrazide small molecule inhibitor. This study provides a theoretical basis for further studies on the model for the development of PAC1R target drugs.
The Synthesis of PACAP and the Construction of Its Expression Vector

刘松财,张永亮,任晓慧,戴建威,张玉静

DOI: https://doi.org/10.3969/j.issn.1005-4545.2004.05.015

2004-01-01

Abstract:Pituitary adenylate cyclase activating polypeptide(PACAP) is a recently isolated bioactive polypeptide.In this research,PACAP gene was cloned in an attempt to express its recombinant peptide for experimantal and clinical application.We have synthesized 10 fregments according to sequence of PACAP gene.PACAP gene was amplified step by step for 5 times.It is 205 bp in length including signal peptide sequence and two restriction enzymic sites(SmaⅠ and XbaⅠ).Amplified PACAP DNA was ligated with prepared fragments of pIRES1-neo(SmaⅠ and XbaⅠ),then transformed to JM109.We selected and identified the positive clones by PCR and digestion with SmaⅠ and XbaⅠ.Sequencing result showed that sequence of PACAP gene has synthesized successfully.Which has the potential value in medical and veterinary clinical application.
Expression, Identification and Biological Effects of the Novel Recombination Protein, Pacap38-Nta, with High Bioactivity

Lusheng Wu,Jing Wang,Xiaojia Chen,An Hong

DOI: https://doi.org/10.3892/ijmm.2014.2017

IF: 5.314

2014-01-01

International Journal of Molecular Medicine

Abstract:Pituitary adenylate cyclase‑activating polypeptide (PACAP) is a type of neuropeptide with multiple biological functions. However, it has a short half‑life period in the body, ~3 to 5 min, restricting its further development as a drug that can promote the recovery of nerve injury. In vitro and in vivo experiments have shown that PACAP can repair the epithelial cell on the surface of the injured cornea, as PACAP can act on the trigeminal nerve cell to secrete other active neurotransmitters, which can promote corneal epithelial cell proliferation and differentiation. In the present study, PACAP is connected to the N‑terminal agrin domain (NtA) with a genetic engineering method, which allows the function of repairing the injured nerve. Notably, the recombinant polypeptide can interact with laminin, improving the biological effect of PACAP in repairing the injured nerve. In the study, the recombinant protein was constructed by combining PACAP38 and NtA by genetic engineering, and it is expressed in the pronucleus escherichia coli. The recombinant protein, PACAP38‑NtA, is obtained with a two‑step purification method, including anion‑exchange chromatography and Ni‑affinity chromatography, with the purity reaching >90%. The in vitro experiment has shown that this recombinant protein not only has the neurotrophy and neural restoration function of PACAP, but also has the function of an anchoring protein as laminin interacts with NtA. According to the in vitro anti‑apoptosis, PC12 axon growth and ELISA experiments, this protein has the biological activity of a recombinant protein. PACAP38‑NtA also has an anchoring function as NtA and laminin interact with good biological activity.
Pituitary adenylate cyclase-activating polypeptide induces translocation of its G-protein-coupled receptor into caveolin-enriched membrane microdomains, leading to enhanced cyclic AMP generation and neurite outgrowth in PC12 cells.

Weishi Zhang,Wei Duan,Nam Sang Cheung,Zhili Huang,Ke Shao,Qiu-Tian Li

DOI: https://doi.org/10.1111/j.1471-4159.2007.04813.x

2007-01-01

Journal of Neurochemistry

Abstract:Pituitary adenylate cyclase-activating polypeptide (PACAP), a member of the secretin/glucagon/vasoactive intestinal peptide family expressed throughout the nervous system, binds to the PACAP-specific G-protein-coupled receptor family members to promote both neuronal differentiation and survival. Although the PACAP receptor is known to activate its effector protein, adenylate cyclase (AC), and thus enhance cAMP generation, the molecular mechanism utilized by the receptor to activate AC is lacking. Here, we show that PACAP induces neurite outgrowth in PC12 cells by induction of translocation of the PACAP type 1 receptor (PAC1R) into caveolin-enriched Triton X-100-insoluble microdomains, leading to stronger PAC1R-AC interaction and elevated cAMP production. Moreover, we demonstrate that translocation of PAC1R is blocked by various treatments that selectively disrupt caveolae. As a result, intracellular cAMP level is decreased and consequently the PACAP-induced neurite outgrowth retarded. In contrast, addition of exogenous ganglioside GM1 to the cells shows the opposite effects. These results therefore identify the PACAP-induced translocation of its G-protein-coupled receptor into caveolae, where both AC and the regulating G-proteins reside, as the key molecular event in activating AC and inducing cAMP-mediated differentiation of PC12 cells.
The TAT Peptide Endows PACAP with an Enhanced Ability to Traverse Bio-Barriers

Rongjie Yu,Zhixing Zeng,Xiaoling Guo,HuaHua Zhang,Xiaofei Liu,Yong Ding,Jiansu Chen

DOI: https://doi.org/10.1016/j.neulet.2012.08.005

IF: 3.197

2012-01-01

Neuroscience Letters

Abstract:Pituitary adenylate cyclase-activating polypeptide (PACAP) is a potential therapeutic neuropeptide. The 11-amino acid human immunodeficiency virus TAT protein transduction domain is able to deliver protein cargoes across the cell membrane and the blood-brain barrier. A novel fusion protein PACAP-TAT, containing TAT at the C-terminus of PACAP was therefore produced and studied for the ability to cross blood barriers. The gene encoding PACAP-TAT was cloned into the expression vector pKYB, and the target peptide PACAP-TAT was purified using the Intein Mediated Purification with an Affinity Chitin-binding Tag (IMPACT) system. The results of cell assays showed that PACAP-TAT stimulated the cell viability of PAC1-CHO cells with the same potency as PACAP, which indicated that the fusion of TAT did not affect the ability of PACAP-TAT to activate the PACAP-specific receptor PAC1. The transfer efficiencies of PACAP-TAT and PACAP across the blood-brain barrier (BBB), blood-air barrier (BAB) and blood-testis barrier (BTB) were assayed using peptides labeled with fluorescein isothiocyanate (FITC). The results showed that PACAP-TAT traversed blood barriers with an efficiency approximately 2.5-fold greater than PACAP. Fluorescence microscopic examination showed that PACAP-TAT traversed the BBB significantly more efficiently than PACAP. Furthermore, intraperitoneal (i.p.) injection of PACAP-TAT induced a stronger inhibitory effect on food intake than PACAP (p<0.01, PACAP-TAT vs. PACAP), which indicated that TAT helped to increase the localization of PACAP-TAT in the brain. Preparation of PACAP-TAT with the enhanced ability to cross biological barriers will improve its route of administration and expand its scope of application.
Gene Cloning and Expression of PACAP and Study of Its Biological Activity

ZY Chen,YF Chai,C He,CL Lu,XF Wu

2001-01-01

Abstract:In order to study the expression and the feasibility of scaled production of neuropeptide in the routine expression system such as E.coli with the pituitary adenylate cyclase activating polypep tide(PACAP) as an example, the following experiments were carried out. First, on the basis of the reported amino acid sequence of PACAP, DNA sequence of PACAP w as deduced and six partially complementary oligonucleotide fragments were design ed. The coding region of PACAP was obtained by renaturing the DNA fragments and ligation and identified by DNA sequencing. The coding region of PACAP was cloned into plasmid pGEX-4T-3 and transformed into E.coli BL21(DE3 ). An expression strain BLPACAP was selected. SDS-PAGE analysis revealed that t he GST-PACAP fusion protein was highly expressed and accumulated to about 30% o f the total bacterial proteins. By affinity chromatography, up to 90% GST-PACAP was purified by one step from bacterial lysate. The purified protein could prom ote neurite outgrowth of PC12 cells and the survival of spinal cord neurons.
Exploring the Role of Neuropeptide PACAP in Cytoskeletal Function Using Spectroscopic Methods

Roland Gábor Vékony,Andrea Tamás,András Lukács,Zoltán Ujfalusi,Dénes Lőrinczy,Veronika Takács-Kollár,Péter Bukovics

DOI: https://doi.org/10.3390/ijms25158063

IF: 5.6

2024-07-25

International Journal of Molecular Sciences

Abstract:The behavior and presence of actin-regulating proteins are characteristic of various clinical diseases. Changes in these proteins significantly impact the cytoskeletal and regenerative processes underlying pathological changes. Pituitary adenylate cyclase-activating polypeptide (PACAP), a cytoprotective neuropeptide abundant in the nervous system and endocrine organs, plays a key role in neuron differentiation and migration by influencing actin. This study aims to elucidate the role of PACAP as an actin-regulating polypeptide, its effect on actin filament formation, and the underlying regulatory mechanisms. We examined PACAP27, PACAP38, and PACAP6-38, measuring their binding to actin monomers via fluorescence spectroscopy and steady-state anisotropy. Functional polymerization tests were used to track changes in fluorescent intensity over time. Unlike PACAP27, PACAP38 and PACAP6-38 significantly reduced the fluorescence emission of Alexa488-labeled actin monomers and increased their anisotropy, showing nearly identical dissociation equilibrium constants. PACAP27 showed weak binding to globular actin (G-actin), while PACAP38 and PACAP6-38 exhibited robust interactions. PACAP27 did not affect actin polymerization, but PACAP38 and PACAP6-38 accelerated actin incorporation kinetics. Fluorescence quenching experiments confirmed structural changes upon PACAP binding; however, all studied PACAP fragments exhibited the same effect. Our findings indicate that PACAP38 and PACAP6-38 strongly bind to G-actin and significantly influence actin polymerization. Further studies are needed to fully understand the biological significance of these interactions.

biochemistry & molecular biology,chemistry, multidisciplinary
Positive allosteric regulation of PAC1-R up-regulates<?A3B2 ACK?>PAC1-R and its specific ligand PACAP

Fan Guangchun,Tao Zhengxin,Chen Shang,Zhang Huahua,Yu Rongjie

DOI: https://doi.org/10.3724/abbs.2022041

IF: 3.7

2022-01-01

Acta Biochimica et Biophysica Sinica

Abstract:PAC1-R is a recognized preferential receptor for the neuropeptide of pituitary adenylate cyclase-activating polypeptide (PACAP), which mediates neuroprotective and nerve regenerative activities of PACAP. In this study, we found that in both PAC1R-CHO cells with high expression of PAC1R-eGFP and retinal ganglion cells (RGC-5) with the natural expression of PAC1-R, oligo-peptide PACAP(28-38) and the positively charged arginine-rich penetrating peptide TAT, as positive allosteric modulators of PAC1-R, significantly trigger the nuclear translocation of PAC1-R. The chromatin immunoprecipitation (ChIP)-PCR results show that the nuclear translocated PAC1-R binds with the promoter regions of PAC1-R and its specific ligand PACAP. The up-regulated promoter activities of PAC1-R and PACAP induced by PACAP(28-38) or TAT are positively correlative with the increase of the expression levels of PAC1-R and PACAP. Moreover, the nuclear translocation of PAC1-R induced by PACAP(28-38) or TAT is significantly inhibited by the mutation of PAC1-R on Cys25 and the palmitoylation inhibitor 2-bromopalmitate. Meanwhile, the increase in both PAC1-R and PACAP levels and the neuroprotective activities of PACAP(28-38) and TAT in MPP-induced cell model of Parkinson’s disease are synchronously inhibited by 2-bromopalmitate, which are positively correlated with the nuclear translocation of PAC1-R induced by PACAP(28-38) or TAT. Bioinformatics analysis and motif enrichment analysis following ChIP-sequencing show that the transcription factors including SP1, Zic2, GATA1, REST and YY1 may be recruited by nuclear PAC1-R and involved in regulating the promoter activities of PAC1-R and PACAP. ChIP-sequencing and related bioinformatics analysis show that the downstream target genes regulated by the nuclear PAC1-R are mostly involved in the process of cellular stress and related to neuroprotection, neuronal genesis and development.
Preparation and Activity Identification of Recombinant PACAP-PTD

LIU Xiao-fei,YU Rong-jie,WANG Jing-jing,SU Hang,HUANG Lin,CHEN Jian-su

DOI: https://doi.org/10.3969/j.issn.1004-311x.2011.03.067

2012-01-01

Abstract:[Objective] This study aimed to prepare recombinant protein PACAP-PTD and identify its activity.[Method] The gene that encodes fusion protein PACAP-PTD was cloned into the expression vector pKYB to construct recombinant expression vector pKYB-PACAP-PTD,which was then transformed into E.coli ER2566.The fusion protein consisting of PACAP-PTD,intein and chitin was induced with IPTG to express.Finally,the target fusion protein PACAP-PTD was purified with purification system mediated by IMPACT(Intein Mediated Purification with an Affinity of chitin-binding Tag),and its activity was identified.[Result] The molecular weight of target protein determined with laser time-of-flight mass spectrometry was consistent with the theoretical value.The recombinant protein PACAP-PTD could effectively cross the blood-brain barrier.[Conclusion] The construction and preparation of the fusion protein PACAP-PTD not only lays foundation for further study on its biological function,but also improves the route of PACAP administration,and thus expands its scope of application.
Positive Allosteric Regulation of PAC1-R Up-Regulates&lt;?a3b2 ACK?&gt;PAC1-R and Its Specific Ligand PACAP

Guangchun Fan,Zhengxin Tao,Chao Shang,Huahua Zhang,Rongjie Yu

DOI: https://doi.org/10.3724/abbs.2022041

IF: 3.7

2022-01-01

Acta Biochimica et Biophysica Sinica

Abstract:PAC1-R is a recognized preferential receptor for the neuropeptide of pituitary adenylate cyclase-activating polypeptide (PACAP), which mediates neuroprotective and nerve regenerative activities of PACAP. In this study, we found that in both PAC1R-CHO cells with high expression of PAC1R-eGFP and retinal ganglion cells (RGC-5) with the natural expression of PAC1-R, oligo-peptide PACAP(28-38) and the positively charged arginine-rich penetrating peptide TAT, as positive allosteric modulators of PAC1-R, significantly trigger the nuclear translocation of PAC1-R. The chromatin immunoprecipitation (ChIP)-PCR results show that the nuclear translocated PAC1-R binds with the promoter regions of PAC1-R and its specific ligand PACAP. The up-regulated promoter activities of PAC1-R and PACAP induced by PACAP(28-38) or TAT are positively correlative with the increase of the expression levels of PAC1-R and PACAP. Moreover, the nuclear translocation of PAC1-R induced by PACAP(28-38) or TAT is significantly inhibited by the mutation of PAC1-R on Cys25 and the palmitoylation inhibitor 2-bromopalmitate. Meanwhile, the increase in both PAC1-R and PACAP levels and the neuroprotective activities of PACAP(28-38) and TAT in MPP-induced cell model of Parkinson ' s disease are synchronously inhibited by 2-bromopalmitate, which are positively correlated with the nuclear translocation of PAC1-R induced by PACAP(28-38) or TAT. Bioinformatics analysis and motif enrichment analysis following ChIP-sequencing show that the transcription factors including SP1, Zic2, GATA1, REST and YY1 may be recruited by nuclear PAC1-R and involved in regulating the promoter activities of PAC1-R and PACAP. ChIP-sequencing and related bioinformatics analysis show that the downstream target genes regulated by the nuclear PAC1-R are mostly involved in the process of cellular stress and related to neuroprotection, neuronal genesis and development.
Positive allosteric regulation of PAC1-R up-regulates PAC1-R and its specific ligand PACAP

Guangchun Fan,Zhengxin Tao,Shang Chen,Huahua Zhang,Rongjie Yu

DOI: https://doi.org/10.3724/abbs.2022041

2022-05-25

Abstract:PAC1-R is a recognized preferential receptor for the neuropeptide of pituitary adenylate cyclase-activating polypeptide (PACAP), which mediates neuroprotective and nerve regenerative activities of PACAP. In this study, we found that in both PAC1R-CHO cells with high expression of PAC1R-eGFP and retinal ganglion cells (RGC-5) with the natural expression of PAC1-R, oligo-peptide PACAP(28-38) and the positively charged arginine-rich penetrating peptide TAT, as positive allosteric modulators of PAC1-R, significantly trigger the nuclear translocation of PAC1-R. The chromatin immunoprecipitation (ChIP)-PCR results show that the nuclear translocated PAC1-R binds with the promoter regions of PAC1-R and its specific ligand PACAP. The up-regulated promoter activities of PAC1-R and PACAP induced by PACAP(28-38) or TAT are positively correlative with the increase of the expression levels of PAC1-R and PACAP. Moreover, the nuclear translocation of PAC1-R induced by PACAP(28-38) or TAT is significantly inhibited by the mutation of PAC1-R on Cys25 and the palmitoylation inhibitor 2-bromopalmitate. Meanwhile, the increase in both PAC1-R and PACAP levels and the neuroprotective activities of PACAP(28-38) and TAT in MPP-induced cell model of Parkinson ' s disease are synchronously inhibited by 2-bromopalmitate, which are positively correlated with the nuclear translocation of PAC1-R induced by PACAP(28-38) or TAT. Bioinformatics analysis and motif enrichment analysis following ChIP-sequencing show that the transcription factors including SP1, Zic2, GATA1, REST and YY1 may be recruited by nuclear PAC1-R and involved in regulating the promoter activities of PAC1-R and PACAP. ChIP-sequencing and related bioinformatics analysis show that the downstream target genes regulated by the nuclear PAC1-R are mostly involved in the process of cellular stress and related to neuroprotection, neuronal genesis and development.
Effects of Cyclopeptide C*HSDGIC* from the Cyclization of PACAP (1–5) on the Proliferation and UVB-induced Apoptosis of the Retinal Ganglion Cell Line RGC-5

Yong Ding,Huanhuan Cheng,Rongjie Yu,Cuicui Tang,Xiaofei Liu,Jiansu Chen

DOI: https://doi.org/10.1016/j.peptides.2012.06.003

IF: 3.867

2012-01-01

Peptides

Abstract:Pituitary adenylate cyclase-activating polypeptide (PACAP) is a neuropeptide that confers potent neurotrophic and neuroprotective effects. Cyclopeptide C*HSDGIC* (CHC), which results from the cyclization of PACAP (1-5) with disulfide, has been demonstrated to represent a potent agonist for the PACAP-specific receptor PAC1 which mediates the majority of PACAP's effects. In this study, the expression of PAC1 in a rat retinal ganglion cell line (RGC-5) was confirmed using a western blot analysis, and it was determined that CHC promoted the proliferation of RGC-5 cells using the cell counting kit-8 (CCK8) assay and flow cytometry. Furthermore, the treatment of CHC attenuated the decrease of cell viability in cells exposed to UVB irradiation. Flow cytometry and a JC-1 assay revealed that the CHC treatment protected the RGC-5 cells against UVB-induced apoptosis. In addition, similar to PACAP, the anti-apoptotic effect of CHC was related to the down-regulation of caspase-3. In summary, these results demonstrate for the first time that PAC1 is present in RGC-5 cells and that CHC, a cyclopeptide from PACAP, promotes RGC-5 cell proliferation and attenuates UVB-induced apoptosis. (C) 2012 Elsevier Inc. All rights reserved.
Investigating the impact of PACAP on thermal stability of G-actin by differential scanning calorimetry

Péter Bukovics,Andrea Tamás,Gábor Tóth,Dénes Lőrinczy

DOI: https://doi.org/10.1007/s10973-024-13289-z

IF: 4.755

2024-06-15

Journal of Thermal Analysis and Calorimetry

Abstract:Pituitary adenylate cyclase-activating polypeptide (PACAP) is a bioactive peptide known for its diverse effects on the nervous system. While numerous studies have demonstrated the neuroprotective properties of PACAP, its role in tissue regeneration and potential as a therapeutic agent remain to be fully understood. Specifically, the understanding of PACAP's impact on cytoskeletal dynamics, particularly the organization and disorganization of actin filament networks, is limited due to the scarcity of in vitro studies in this area. Additionally, the interaction between PACAP and actin has been minimally explored, and the influence of PACAP on the thermal stability of actin is completely unknown. To address these gaps, the current study aimed to investigate the impact of different forms and fragments of PACAP on the thermal denaturation and renaturation of Ca 2+ -G-actin using a differential scanning calorimetry (DSC) approach. Our primary objective was to determine whether PACAP modulates the thermal stability of Ca 2+ -G-actin and establish a temperature-dependent pattern of any structural alterations that may occur as a result of PACAP interaction. Two PACAP forms exist in vivo: the 38 amino-acid length PACAP38 and the PACAP27, the latter truncated at the C-terminal. In the PACAP38 + Ca 2+ -G-actin mixture, the DSC scans exhibited a mild decrease in actin denaturation temperature compared to the control, plus an exotherm appeared in the high-temperature range with a significantly increased calorimetric enthalpy. The truncated PACAP27 produced a slight increase in actin denaturation temperature with the same exotherm without significant alteration in enthalpy. In PACAP6-38 mixture (i.e., an artificial fragment of PACAP38 + Ca 2+ -G-actin), there was no change in the denaturation temperature of actin and no plus exotherm, but significant Δ H cal was observed. With the modified PACAP6-27 (another artificial fragment), the exotherm was absent, but the actin denaturation temperature and enthalpy increased compared to the control. Through this research, we sought to elucidate the underlying mechanisms of PACAP's effects on actin dynamics and provide valuable insights into the potential therapeutic applications of PACAP in the context of cytoskeletal organization and neuronal regeneration. The findings of this study may contribute to the development of novel strategies targeting actin-related processes for neuroprotection and neural tissue repair.

chemistry, physical, analytical,thermodynamics
Dimer-Dependent Intrinsic/Basal Activity of the Class B G Protein-Coupled Receptor PAC1 Promotes Cellular Anti-Apoptotic Activity Through Wnt/β-Catenin Pathways That Are Associated with Dimer Endocytosis

Rongjie Yu,Zekai Cui,Mei Li,Yanxu Yang,Jiaping Zhong

DOI: https://doi.org/10.1371/journal.pone.0113913

IF: 3.7

2014-01-01

PLoS ONE

Abstract:The high expression of PACAP (pituitary adenylate cyclase-activating polypeptide)-preferring receptor PAC1 is associated with nerve injury and tumors. Our previous report (Yu R, et al. PLoS One 2012; 7: e51811) confirmed the dimerization of PAC1 and found that the M-PAC1 mutation in the N-terminal first Cys/Ala lost the ability to form dimers. In this study, Chinese hamster ovary (CHO-K1) cells overexpressing wild-type PAC1 (PAC1-CHO) had significantly higher anti-apoptotic activities against serum withdrawal-induced apoptosis associated with a lower caspase 3 activity and a higher Bcl-2 level in a ligand-independent manner than those of CHO cells overexpressing the mutant M-PAC1 (M-PAC1-CHO). PAC1-CHO had significantly higher β-catenin, cyclin D1 and c-myc levels corresponding to the Wnt/β-catenin signal than did M-PAC1-CHO. In addition, the Wnt/β-catenin pathway inhibitor XAV939 significantly inhibited the anti-apoptotic activities of PAC1-CHO. Top-flash assays demonstrated that PAC1-CHO had a significantly stronger Wnt/β-catenin signal than did M-PAC1-CHO. Acetylcysteine (NAC) as an inhibitor of the dimerization of PAC1 inhibited the anti-apoptotic activities that were endowed by PAC1 and decreased the Wnt/β-catenin signal in Top-flash assays. In the PAC1 Tet (tetracycline)-on inducible gene expression system by doxycycline (Dox), higher expression levels of PAC1 resulted in higher anti-apoptotic activities that were associated with a stronger Wnt/β-catenin signal. A similar correlation was also found with the down-regulation of PAC1 in the Neuro2a neuroblastoma cell. BiFC combined with fluorescence confocal imaging indicated that during serum-withdrawal-induced apoptosis, PAC1 dimers displayed significant endocytosis. These findings indicate that PAC1 has ligand-independent and dimer-dependent intrinsic/basal activity, conferring cells with anti-apoptotic activities against serum withdrawal, which is involved in the Wnt/β-catenin signal and is associated with the endocytosis of PAC1 dimers. The discovery and study of the dimer-dependent basal activity of PAC1 not only help us understand the physiological and pathological role of PAC1 but also promote the development of drugs targeting PAC1.
VIP and PACAP

Jan Fahrenkrug

DOI: https://doi.org/10.1007/400_2009_24

Abstract:Vasoactive intestinal polypeptide (VIP) is derived from a 170 amino acid precursor which in addition is processed to preproVIP 22-79, PHI, preproVIP 111-122 and preproVIP 156-170. All preproVIP-derived peptides have been shown in normal tissue and VIP-producing cell lines and elevated quantities occur in plasma and tumour tissues from patients with VIP-producing tumours. In some tissues the dibasic cleavage site after PHI is uncleaved resulting in a C-terminally extended form, PHV. PHI and VIP are present in a 1:1 molar ratio in large dense core vesicles and released in roughly equimolar amounts. Carboxyamidation of VIP and PHI is not critical and glycine-extended forms of both peptides have been demonstrated. Pituitary adenylate cyclase activating polypeptide (PACAP) is derived from a 170 amino acid long precursor, which gives rise to PACAP 38, PACAP 27 and PACAP related peptide (PRP). All peptides are present in tissue, the dominating form being PACAP 38. Prohormone convertase (PC) 1 and 2 seem to be involved in the processing of PACAP, except in the testes and ovary, where the PACAP precursor is substrate for PC4.
The Effects of N-terminal HSDCIF Motif of Family B G-Protein-coupled Receptor PAC1 on Its Cell Surface Trafficking and Dimerization

GUO Xiao-Ling,YU Rong-Jie,ZENG Zhi-Xing,LI Mei,ZHONG Jia-Ping,ZHANG Hua-Hua

DOI: https://doi.org/10.13865/j.cnki.cjbmb.2013.09.004

2013-01-01

Abstract:PAC1 is a pituitary adenylate cyclase activating polypeptide(PACAP) receptor to mediate neural protection functions.It belongs to the B family of G-protein-coupled receptors(GPCRs),and is suggested as an important target for drug development for neurological diseases.The HSDCIF(His-SerAsp-Gly-Ile-Phe) functional motif located in the first N-terminal extracellular domain(EC1) of PAC1 has a high homology with PACAP(1-6).A PAC1 HISCIF motif deletion mutant named D-PAC1 was constructed.Vectors of D-PAC1-EYFP with enhanced yellow fluorescent protein(EYFP) and D-PAC1Rluc were used for the bioluminescent energy transfer(BRET) assay;D-PAC1-EYFP / N and D-PAC1EYFP / C were used for complements bimolecular fluorescence(BiFC).Immunofluorescence was used to detect D-PAC1 expression and fluorescence confocal microscopy was used for its cellular trafficking observation.Western blot,BRET and BiFC were used for detecting D-PAC1 homologous dimerization.The effects of chemically synthesized oligo-peptide HSDCIF on the homologous dimerization of PAC1 were also detected.The results showed that D-PAC1 failed to traffick onto the cell membrane to form dimers,but retentioned in the endoplasmic reticulum.Chemically synthesized HSDCIF peptide competitively inhibited dimerization of PAC1.

The Distribution and Biological Fuction of Pituitary Adenylate Cyclase Activating Polypeptide

Research advance of pituitary adenylate cyclase activating polypeptide

Pituitary Adenylate Cyclase-Activating Polypeptide and Its Receptors: 20 Years after the Discovery

The Distrion of PACAP Receptor on the Cardiovascular Tissues and Cells

Expression,Purification and Activity of Pituitary Adenylate Cyclase-activting Polypeptide 38 and Its Derivative

Homology Modeling and Molecular Docking of Human Pituitary Adenylate Cyclase-Activating Polypeptide I Receptor

The Synthesis of PACAP and the Construction of Its Expression Vector

Expression, Identification and Biological Effects of the Novel Recombination Protein, Pacap38-Nta, with High Bioactivity

Pituitary adenylate cyclase-activating polypeptide induces translocation of its G-protein-coupled receptor into caveolin-enriched membrane microdomains, leading to enhanced cyclic AMP generation and neurite outgrowth in PC12 cells.

The TAT Peptide Endows PACAP with an Enhanced Ability to Traverse Bio-Barriers

Gene Cloning and Expression of PACAP and Study of Its Biological Activity

Exploring the Role of Neuropeptide PACAP in Cytoskeletal Function Using Spectroscopic Methods

Positive allosteric regulation of PAC1-R up-regulates<?A3B2 ACK?>PAC1-R and its specific ligand PACAP

Preparation and Activity Identification of Recombinant PACAP-PTD

Positive Allosteric Regulation of PAC1-R Up-Regulates&amp;lt;?a3b2 ACK?&amp;gt;PAC1-R and Its Specific Ligand PACAP

Positive allosteric regulation of PAC1-R up-regulates PAC1-R and its specific ligand PACAP

Effects of Cyclopeptide C*HSDGIC* from the Cyclization of PACAP (1–5) on the Proliferation and UVB-induced Apoptosis of the Retinal Ganglion Cell Line RGC-5

Investigating the impact of PACAP on thermal stability of G-actin by differential scanning calorimetry

Dimer-Dependent Intrinsic/Basal Activity of the Class B G Protein-Coupled Receptor PAC1 Promotes Cellular Anti-Apoptotic Activity Through Wnt/β-Catenin Pathways That Are Associated with Dimer Endocytosis

VIP and PACAP

The Effects of N-terminal HSDCIF Motif of Family B G-Protein-coupled Receptor PAC1 on Its Cell Surface Trafficking and Dimerization

Positive Allosteric Regulation of PAC1-R Up-Regulates<?a3b2 ACK?>PAC1-R and Its Specific Ligand PACAP

Effects of Cyclopeptide CHSDGIC from the Cyclization of PACAP (1–5) on the Proliferation and UVB-induced Apoptosis of the Retinal Ganglion Cell Line RGC-5